Brandywine Global Investment Management LLC Acquires 7,444 Shares of Genpact Limited $G

Market Beat
2025.11.24 08:28
portai
I'm PortAI, I can summarize articles.

Brandywine Global Investment Management LLC increased its stake in Genpact Limited by 7.5% in Q2, acquiring 7,444 additional shares. Other institutional investors also adjusted their positions in Genpact. The company's stock opened at $44.35, with a market cap of $7.65 billion. Genpact reported Q3 earnings of $0.97 per share, surpassing estimates, and announced a quarterly dividend of $0.17. Recent insider sales were disclosed, with significant transactions by SVPs Piyush Mehta and Sameer Dewan.

Brandywine Global Investment Management LLC grew its stake in shares of Genpact Limited (NYSE:G - Free Report) by 7.5% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 106,842 shares of the business services provider's stock after purchasing an additional 7,444 shares during the quarter. Brandywine Global Investment Management LLC owned approximately 0.06% of Genpact worth $4,702,000 at the end of the most recent quarter.

  • What’s on the Thanksgiving Table? A Stock Pick for Every Course

Several other institutional investors also recently added to or reduced their stakes in the stock. Hussman Strategic Advisors Inc. purchased a new position in shares of Genpact during the second quarter worth approximately $3,697,000. Access Investment Management LLC bought a new position in Genpact in the second quarter worth approximately $9,423,000. Strs Ohio increased its holdings in Genpact by 51.4% during the 2nd quarter. Strs Ohio now owns 56,217 shares of the business services provider's stock worth $2,474,000 after purchasing an additional 19,075 shares during the period. Asset Management One Co. Ltd. increased its holdings in Genpact by 149.5% during the 2nd quarter. Asset Management One Co. Ltd. now owns 33,618 shares of the business services provider's stock worth $1,480,000 after purchasing an additional 20,146 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. raised its position in Genpact by 8.8% during the 2nd quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,501,688 shares of the business services provider's stock valued at $110,099,000 after purchasing an additional 203,015 shares in the last quarter. Hedge funds and other institutional investors own 96.03% of the company's stock.

Genpact Stock Up 1.4%

NYSE:G opened at $44.35 on Monday. The company's 50-day simple moving average is $41.17 and its 200-day simple moving average is $42.96. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.51 and a current ratio of 1.51. Genpact Limited has a fifty-two week low of $37.49 and a fifty-two week high of $56.76. The stock has a market capitalization of $7.65 billion, a P/E ratio of 14.31, a P/E/G ratio of 1.42 and a beta of 0.85.

  • 5 Small-Cap Stocks With Impressive Growth and Upside Potential

Genpact (NYSE:G - Get Free Report) last posted its earnings results on Thursday, November 6th. The business services provider reported $0.97 EPS for the quarter, beating analysts' consensus estimates of $0.90 by $0.07. Genpact had a net margin of 11.01% and a return on equity of 22.55%. The company had revenue of $1.29 billion during the quarter, compared to analysts' expectations of $1.27 billion. During the same quarter in the prior year, the company posted $0.85 earnings per share. Genpact's revenue for the quarter was up 6.6% compared to the same quarter last year. Genpact has set its FY 2025 guidance at 3.600-3.610 EPS. Q4 2025 guidance at 0.930-0.940 EPS. On average, equities analysts anticipate that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 23rd. Stockholders of record on Tuesday, December 9th will be given a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, December 9th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.5%. Genpact's dividend payout ratio (DPR) is presently 21.94%.

Insiders Place Their Bets

  • 4 Cold-Weather Stocks to Buy as Winter Spending Heats Up

In other news, SVP Piyush Mehta sold 76,902 shares of the business's stock in a transaction dated Friday, September 12th. The stock was sold at an average price of $42.58, for a total transaction of $3,274,487.16. Following the sale, the senior vice president owned 134,880 shares in the company, valued at approximately $5,743,190.40. The trade was a 36.31% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Sameer Dewan sold 26,531 shares of the stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $44.70, for a total transaction of $1,185,935.70. Following the completion of the transaction, the senior vice president directly owned 62,617 shares of the company's stock, valued at $2,798,979.90. The trade was a 29.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 161,183 shares of company stock valued at $6,970,760. 2.80% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

G has been the topic of a number of recent research reports. Weiss Ratings reissued a "hold (c)" rating on shares of Genpact in a research report on Wednesday, October 8th. Citigroup upgraded shares of Genpact to a "hold" rating in a report on Thursday, October 23rd. Wall Street Zen raised shares of Genpact from a "hold" rating to a "buy" rating in a research report on Saturday, November 15th. Needham & Company LLC upped their price target on shares of Genpact from $50.00 to $53.00 and gave the stock a "buy" rating in a research report on Friday, August 8th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Genpact from $55.00 to $50.00 and set a "neutral" rating on the stock in a report on Wednesday, August 20th. Three investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $51.13.

Read Our Latest Stock Report on G

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Stories

  • Five stocks we like better than Genpact
  • What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
  • DoorDash’s Recent Stock Dip Equals 60% Upside
  • How to invest in marijuana stocks in 7 steps
  • Wall Street Loves Williams-Sonoma Right Now—Here’s Why the Stock Could Soar in 2026
  • What Are Dividend Champions? How to Invest in the Champions
  • Meta Wins FTC Fight, Keeps Instagram Growth Machine Intact

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here